Biopharmaceuticals
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
Aim & Scope
This section is dedicated to research on the therapeutic, diagnostic, prognostic and immunoprophylactic developments of important biological macromolecules built from amino acids, sugars, nucleic acids, comprising small basic units of which they are composed, and mimetics produced by chemical synthesis. Contributions focusing on biopharmaceutical applications of more complex entities, such as phages, viruses, exosomes and stem cells, among others, are also welcome. Also reports on structure and molecular interactions determinant for biopharmaceuticals bioactivity or pharmaceutical applications, e.g. by computational and NMR studies are also accepted. Download Section Flyer
Keywords
- Peptides
- Proteins
- RNA
- DNA
- Nucleic Acids
- Aptamers
- Carbohydrates
- Glycans
- Polysaccharides
- Macromolecules
- Chemical Synthesis
- Ribonucleoproteins
- Antibodies
- Phages
- Viruses
- Therapeutic Tools
- Peptidomimetics
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- HIV and Viral Hepatitis: Prevention, Treatment and Coinfection (Deadline: 30 November 2024)
- Cardiovascular Diseases: Where Do We Stand with Human-Derived Stem Cells? (Deadline: 30 November 2024)
- The 20th Anniversary of Pharmaceuticals: Advances in Peptide Drug Design and Development: From Sequences to Drug Candidates (Deadline: 15 December 2024)
- Peptide Drug Conjugates and Their Applications (Deadline: 20 December 2024)
- The 20th Anniversary of Pharmaceuticals—Emerging Trends in Biopharmaceuticals (Deadline: 22 December 2024)
- Biological Treatment for Rheumatic Diseases (Deadline: 30 December 2024)
- Glycomimetics and Glycoconjugates in Drug Discovery, 2nd Edition (Deadline: 31 December 2024)
- Antivirals and Targets to Fight RNA Viruses (Deadline: 24 January 2025)
- Stem Cells and Organoids as Tools for Drug Development (Deadline: 25 January 2025)
- Design, Synthesis, and Evaluation of Nucleobase, Nucleoside, and Nucleotide Analogues (Deadline: 25 February 2025)
- Structural and Other Proteomics Approaches in Drug Discovery (Deadline: 25 February 2025)
- Protein and Peptide-Based Drug Delivery (Deadline: 15 March 2025)
- Ultra-Short Peptides as Potential Drug Target Molecules in Pharmaceuticals (Deadline: 20 March 2025)
- Phage Discovery and Phage Therapy (Deadline: 20 March 2025)
- New Advances in Mesenchymal Stromal Cells as Therapeutic Tools, 2nd Edition (Deadline: 31 March 2025)
- Pluripotent Stem Cell for Novel Drug Discovery (Deadline: 22 April 2025)
- Evaluation of the Antitumor Mechanism of Armed Antibodies: 2nd Edition (Deadline: 25 April 2025)
- Therapeutic Applications of Micro-RNA in Cancer Management (Deadline: 30 April 2025)
- β-Lactams and β-Lactamase Inhibitors: Recent Advances (Deadline: 30 April 2025)
- Antiplatelet Therapy in Inflammatory Diseases (Deadline: 20 May 2025)
- Characterization and Quality Control of Biopharmaceuticals Using the Multi-Attribute Method (MAM): Advantages and Challenges (Deadline: 31 May 2025)
- Organ Regeneration by Application of Biomaterials and Stem Cells Technology Tools (Deadline: 12 July 2025)
- 2D and 3D Culture Systems: Current Trends and Biomedical Applications (Deadline: 25 July 2025)
